Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruiwen Zhang

Showing results (11-20 of 200) with videos related to

Pageof 20
Sort By:
Current Cancer Drug Targets|June 28, 2013
Anti-cancer molecular targets of natural productsXiaolin Zi, Ruiwen Zhang
Drug Discovery Today|June 14, 2008
Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?Elizabeth R Rayburn, Ruiwen Zhang
Methods in Molecular Biology (Clifton, N.J.)|January 29, 2016
Pharmacokinetics and Pharmacodynamics in Breast Cancer Animal ModelsWei Wang, Subhasree Nag, Ruiwen Zhang
International Journal of Molecular Medicine|May 23, 2018
CTLA‑4 interferes with the HBV‑specific T cell immune response (Review)Hui Cao, Ruiwen Zhang, Wei Zhang
Optics Express|July 14, 2016
Analysis of acousto-optic interaction based on forward stimulated Brillouin scattering in hybrid phononic-photonic waveguidesRuiwen Zhang, Guodong Chen, Junqiang Sun
Current Pharmaceutical Design|August 17, 2005
Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeuticsHui Wang, Elizabeth Rayburn, Ruiwen Zhang
Plant Physiology and Biochemistry : PPB|October 1, 2018
Genetic and physiological effects of the natural radioactive gas radon on the epiphytic plant Tillandsia brachycaulosPeng Li, Ruiwen Zhang, Guiling Zheng
Open Life Sciences|April 5, 2021
Effects of Foliar Trichomes on the Accumulation of Atmospheric Particulates in <i>Tillandsia Brachycaulos</i>Ruiwen Zhang, Guiling Zheng, Peng Li
Scientific Reports|May 22, 2015
On-chip optical mode conversion based on dynamic grating in photonic-phononic hybrid waveguideGuodong Chen, Ruiwen Zhang, Junqiang Sun
Current Cancer Drug Targets|February 22, 2005
Novel antisense anti-MDM2 mixed-backbone oligonucleotides: proof of principle, in vitro and in vivo activities, and mechanismsRuiwen Zhang, Hui Wang, Sudhir Agrawal
Pageof 20

Showing results (11-20 of 200) with videos related to

Sort By:
Pageof 20
Current Cancer Drug Targets|June 28, 2013
Anti-cancer molecular targets of natural productsXiaolin Zi, Ruiwen Zhang
Drug Discovery Today|June 14, 2008
Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?Elizabeth R Rayburn, Ruiwen Zhang
Methods in Molecular Biology (Clifton, N.J.)|January 29, 2016
Pharmacokinetics and Pharmacodynamics in Breast Cancer Animal ModelsWei Wang, Subhasree Nag, Ruiwen Zhang
International Journal of Molecular Medicine|May 23, 2018
CTLA‑4 interferes with the HBV‑specific T cell immune response (Review)Hui Cao, Ruiwen Zhang, Wei Zhang
Optics Express|July 14, 2016
Analysis of acousto-optic interaction based on forward stimulated Brillouin scattering in hybrid phononic-photonic waveguidesRuiwen Zhang, Guodong Chen, Junqiang Sun
Current Pharmaceutical Design|August 17, 2005
Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeuticsHui Wang, Elizabeth Rayburn, Ruiwen Zhang
Plant Physiology and Biochemistry : PPB|October 1, 2018
Genetic and physiological effects of the natural radioactive gas radon on the epiphytic plant Tillandsia brachycaulosPeng Li, Ruiwen Zhang, Guiling Zheng
Open Life Sciences|April 5, 2021
Effects of Foliar Trichomes on the Accumulation of Atmospheric Particulates in <i>Tillandsia Brachycaulos</i>Ruiwen Zhang, Guiling Zheng, Peng Li
Scientific Reports|May 22, 2015
On-chip optical mode conversion based on dynamic grating in photonic-phononic hybrid waveguideGuodong Chen, Ruiwen Zhang, Junqiang Sun
Current Cancer Drug Targets|February 22, 2005
Novel antisense anti-MDM2 mixed-backbone oligonucleotides: proof of principle, in vitro and in vivo activities, and mechanismsRuiwen Zhang, Hui Wang, Sudhir Agrawal
Pageof 20